On the public citation graph
Systems biology‐embedded target validation: improving efficacy in drug discovery
0 signed · 91 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/wsbm.1173openalex-snapshot
Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine
inferredcites →https://doi.org/10.1002/wsbm.51openalex-snapshot
Systems approaches and algorithms for discovery of combinatorial therapies
inferredcites →https://doi.org/10.1007/978-3-642-25950-0_11openalex-snapshot
Cancer Chronotherapeutics: Experimental, Theoretical, and Clinical Aspects
inferredcites →https://doi.org/10.1007/s00018-010-0619-9openalex-snapshot
Teratogenic effects of thalidomide: molecular mechanisms
inferredcites →https://doi.org/10.1016/j.cbpa.2010.06.166openalex-snapshot
Rational approaches to targeted polypharmacology: creating and navigating protein–ligand interaction networks
inferredcites →https://doi.org/10.1016/j.cell.2004.05.018openalex-snapshot
Protein Tyrosine Phosphatases in the Human Genome
inferredcites →https://doi.org/10.1016/j.cell.2012.03.031openalex-snapshot
Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks
inferredcites →https://doi.org/10.1016/j.drudis.2011.09.007openalex-snapshot
What makes a good drug target?
inferredcites →https://doi.org/10.1016/j.ejps.2008.10.024openalex-snapshot
Identifying mechanisms of chronotolerance and chronoefficacy for the anticancer drugs 5-fluorouracil and oxaliplatin by computational modeling
inferredcites →https://doi.org/10.1016/j.pharmthera.2012.08.008openalex-snapshot
Emerging real-time technologies in molecular medicine and the evolution of integrated ‘pharmacomics’ approaches to personalized medicine and drug discovery
inferredcites →https://doi.org/10.1016/j.reprotox.2004.12.004openalex-snapshot
Dose–response modeling in reproductive toxicology in the systems biology era
inferredcites →https://doi.org/10.1016/j.sbi.2006.01.013openalex-snapshot
Can we rationally design promiscuous drugs?
inferredcites →https://doi.org/10.1016/s0167-7799(01)01811-xopenalex-snapshot
Drug discovery of the future: the implications of the human genome project
inferredcites →https://doi.org/10.1016/s0169-409x(00)00129-0openalex-snapshot
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1
inferredcites →https://doi.org/10.1016/s1359-6446(02)02595-3openalex-snapshot
Fulfilling the promise: drug discovery in the post-genomic era
inferredcites →https://doi.org/10.1038/bjc.1969.41openalex-snapshot
The two “hit” and multiple “hit” theories of carcinogenesis.
inferredcites →https://doi.org/10.1038/clpt.2009.295openalex-snapshot
Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs
inferredcites →https://doi.org/10.1038/msb4100180openalex-snapshot
Network‐based classification of breast cancer metastasis
inferredcites →https://doi.org/10.1038/nature08506openalex-snapshot
Predicting new molecular targets for known drugs
inferredcites →https://doi.org/10.1038/nature11127openalex-snapshot
Chemical genetic discovery of targets and anti-targets for cancer polypharmacology
inferredcites →https://doi.org/10.1038/nchembio.118openalex-snapshot
Network pharmacology: the next paradigm in drug discovery
inferredcites →https://doi.org/10.1038/nrd2381openalex-snapshot
Proteins, drug targets and the mechanisms they control: the simple truth about complex networks
inferredcites →https://doi.org/10.1038/nrd2519openalex-snapshot
Genome-wide association studies: progress and potential for drug discovery and development
inferredcites →https://doi.org/10.1038/nrd2961openalex-snapshot
Lessons from 60 years of pharmaceutical innovation
inferredcites →https://doi.org/10.1038/nrd3025openalex-snapshot
The future of drug development: advancing clinical trial design
inferredcites →https://doi.org/10.1038/nrd3078openalex-snapshot
How to improve R&D productivity: the pharmaceutical industry's grand challenge
inferredcites →https://doi.org/10.1038/nrd3375openalex-snapshot
Phase III and submission failures: 2007–2010
inferredcites →https://doi.org/10.1038/nrd3478openalex-snapshot
Trends in the exploitation of novel drug targets
inferredcites →https://doi.org/10.1038/nrd3981openalex-snapshot
Priorities for improving drug research, development and regulation
inferredcites →https://doi.org/10.1038/srep00052openalex-snapshot
Drug-target network in myocardial infarction reveals multiple side effects of unrelated drugs
inferredcites →https://doi.org/10.1056/nejm199304083281404openalex-snapshot
Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma
inferredcites →https://doi.org/10.1056/nejm200104053441401openalex-snapshot
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
inferredcites →https://doi.org/10.1056/nejmcibr072593openalex-snapshot
Rational Design of Cancer-Drug Combinations
inferredcites →https://doi.org/10.1056/nejmoa040938openalex-snapshot
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
inferredcites →https://doi.org/10.1056/nejmoa1203421openalex-snapshot
Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
inferredcites →https://doi.org/10.1074/mcp.m112.024851openalex-snapshot
Network-based Analysis of Genome Wide Association Data Provides Novel Candidate Genes for Lipid and Lipoprotein Traits
inferredcites →https://doi.org/10.1074/mcp.m500231-mcp200openalex-snapshot
A Novel, Evolutionarily Conserved Protein Phosphatase Complex Involved in Cisplatin Sensitivity
inferredcites →https://doi.org/10.1074/mcp.m900285-mcp200openalex-snapshot
Global Effects of Kinase Inhibitors on Signaling Networks Revealed by Quantitative Phosphoproteomics
inferredcites →https://doi.org/10.1093/nar/gkq1037openalex-snapshot
PROMISCUOUS: a database for network-based drug-repositioning
inferredcites →https://doi.org/10.1093/qjmed/hct163openalex-snapshot
Systems medicine: helping us understand the complexity of disease
inferredcites →https://doi.org/10.1111/febs.12268openalex-snapshot
Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening and knowledge of transporters: where drug discovery went wrong and how to fix it
inferredcites →https://doi.org/10.1111/j.1432-1033.2004.04404.xopenalex-snapshot
Principles behind the multifarious control of signal transduction
inferredcites →https://doi.org/10.1111/j.1476-5381.2012.02020.xopenalex-snapshot
Application of cardiac electrophysiology simulations to pro‐arrhythmic safety testing
inferredcites →https://doi.org/10.1111/j.1742-4658.2008.06846.xopenalex-snapshot
A systems biological approach suggests that transcriptional feedback regulation by dual‐specificity phosphatase 6 shapes extracellular signal‐related kinase activity in RAS‐transformed fibroblasts
inferredcites →https://doi.org/10.1111/j.1742-4658.2012.08522.xopenalex-snapshot
Signalling by protein phosphatases and drug development: a systems‐centred view
inferredcites →https://doi.org/10.1126/science.1056072openalex-snapshot
Principles for the Buffering of Genetic Variation
inferredcites →https://doi.org/10.1126/scisignal.2001212openalex-snapshot
The Mammalian MAPK/ERK Pathway Exhibits Properties of a Negative Feedback Amplifier
inferredcites →https://doi.org/10.1126/scitranslmed.3002588openalex-snapshot
A Computational Model to Predict the Effects of Class I Anti-Arrhythmic Drugs on Ventricular Rhythms
inferredcites →https://doi.org/10.1136/ard.56.1.27openalex-snapshot
The timing of glucocorticoid administration in rheumatoid arthritis
inferredcites →https://doi.org/10.1136/hrt.2005.078782openalex-snapshot
Late sodium current in the pathophysiology of cardiovascular disease: consequences of sodium–calcium overload
inferredcites →https://doi.org/10.1136/hrt.2005.078790openalex-snapshot
Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine
inferredcites →https://doi.org/10.1146/annurev-biochem-090308-173656openalex-snapshot
The Evolution of Protein Kinase Inhibitors from Antagonists to Agonists of Cellular Signaling
inferredcites →https://doi.org/10.1158/0008-5472.can-09-0777openalex-snapshot
Systems Biology Reveals New Strategies for Personalizing Cancer Medicine and Confirms the Role of PTEN in Resistance to Trastuzumab
inferredcites →https://doi.org/10.1182/blood-2007-07-102061openalex-snapshot
Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets
inferredcites →https://doi.org/10.1183/09031936.00078812openalex-snapshot
Application of ’omics technologies to biomarker discovery in inflammatory lung diseases
inferredcites →https://doi.org/10.1186/1755-8794-5-27openalex-snapshot
Network analysis identifies a putative role for the PPAR and type 1 interferon pathways in glucocorticoid actions in asthmatics
inferredcites →https://doi.org/10.1208/aapsj070355openalex-snapshot
Pharmacokinetics/pharmacodynamics and the stages of drug development: Role of modeling and simulation
inferredcites →https://doi.org/10.1371/journal.pcbi.1002129openalex-snapshot
A Systems Biology Approach Identifies Molecular Networks Defining Skeletal Muscle Abnormalities in Chronic Obstructive Pulmonary Disease
inferredcites →https://doi.org/10.1371/journal.pcbi.1002143openalex-snapshot
A Combined Experimental and Mathematical Approach for Molecular-based Optimization of Irinotecan Circadian Delivery
inferredcites →https://doi.org/10.1371/journal.pmed.0030208openalex-snapshot
The Limits of Reductionism in Medicine: Could Systems Biology Offer an Alternative?
inferredcites →https://doi.org/10.1371/journal.pone.0014750openalex-snapshot
Drug Inhibition Profile Prediction for NFκB Pathway in Multiple Myeloma
inferredcites →https://doi.org/10.1371/journal.pone.0048208openalex-snapshot
Aspirin Inhibits Colon Cancer Cell and Tumor Growth and Downregulates Specificity Protein (Sp) Transcription Factors
inferredcites →https://doi.org/10.3109/07420528.2011.597532openalex-snapshot
Prediction of Survival by Neutropenia According To Delivery Schedule of Oxaliplatin–5-Fluorouracil–Leucovorin for Metastatic Colorectal Cancer in a Randomized International Trial (EORTC 05963)
inferredcites →https://doi.org/10.4155/fmc.10.241openalex-snapshot
Protein Tyrosine Phosphatases as Drug Targets: Strategies and Challenges of Inhibitor Development
inferredcites →https://doi.org/10.5167/uzh-63198openalex-snapshot
Improved survival with MEK Inhibition in BRAF-mutated melanoma for the METRIC Study Group
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/med.21487openalex-snapshot
Evolutionary and genetic features of drug targets
inferred← citeshttps://doi.org/10.1002/wsbm.1266openalex-snapshot
Drug discovery and the maze of biological complexity: an editorial essay
inferred← citeshttps://doi.org/10.1007/s12035-026-06155-6openalex-snapshot
Sigma-1 Expression in Chronic Mouse Models of Temporal Lobe Epilepsy
inferred← citeshttps://doi.org/10.1016/b978-0-12-804328-8.00008-5openalex-snapshot
Translational Bioinformatics Methods for Drug Discovery and Development
inferred← citeshttps://doi.org/10.1016/b978-0-443-22326-6.00024-9openalex-snapshot
Repurposing, effects, design, and discovery of drugs in systems biology
inferred← citeshttps://doi.org/10.1016/j.biosystems.2018.08.002openalex-snapshot
Pathway-based gene-gene interaction network modelling to predict potential biomarkers of essential hypertension
inferred← citeshttps://doi.org/10.1016/j.coche.2017.09.004openalex-snapshot
Bioprocess microfluidics: applying microfluidic devices for bioprocessing
inferred← citeshttps://doi.org/10.1016/j.ejcb.2018.01.001openalex-snapshot
Understanding organellar protein folding capacities and assessing their pharmacological modulation by small molecules
inferred← citeshttps://doi.org/10.1016/j.molmet.2020.101127openalex-snapshot
A multicomponent screen for feeding behaviour and nutritional status in Drosophila to interrogate mammalian appetite-related genes
inferred← citeshttps://doi.org/10.1038/nrd4578openalex-snapshot
Mitigating risk in academic preclinical drug discovery
inferred← citeshttps://doi.org/10.1038/s41573-020-0087-3openalex-snapshot
Improving target assessment in biomedical research: the GOT-IT recommendations
inferred← citeshttps://doi.org/10.1038/s41598-024-52484-8openalex-snapshot
Systems biology approaches to identify driver genes and drug combinations for treating COVID-19
inferred← citeshttps://doi.org/10.1080/07391102.2023.2242515openalex-snapshot
Identification of candidate target genes of oral squamous cell carcinoma using high-throughput RNA-Seq data and in silico studies of their interaction with naturally occurring bioactive compounds
inferred← citeshttps://doi.org/10.1089/omi.2018.0074openalex-snapshot
Personalized Herbal Medicine? A Roadmap for Convergence of Herbal and Precision Medicine Biomarker Innovations
inferred← citeshttps://doi.org/10.1093/bib/bbv060openalex-snapshot
Problems, challenges and promises: perspectives on precision medicine
inferred← citeshttps://doi.org/10.1108/mbe-09-2021-0112openalex-snapshot
Contemporary challenges in the European pharmaceutical industry: a systematic literature review
inferred← citeshttps://doi.org/10.18260/1-2--35021openalex-snapshot
Outcomes and Assessment of Three Years of an REU Site in Multiscale Systems Bioengineering
inferred← citeshttps://doi.org/10.2174/1568026615666150112103510openalex-snapshot
Computational and Experimental Advances in Drug Repositioning for Accelerated Therapeutic Stratification
inferred← citeshttps://doi.org/10.22038/ajp.2016.6792openalex-snapshot
Saffron'omics': The challenges of integrating omic technologies.
inferred← citeshttps://doi.org/10.3389/fphys.2019.00096openalex-snapshot
Dynamic Targeting in Cancer Treatment
inferred← citeshttps://doi.org/10.3390/ijms22126184openalex-snapshot
Bioinformatics Accelerates the Major Tetrad: A Real Boost for the Pharmaceutical Industry
inferred← citeshttps://doi.org/10.3390/v13112117openalex-snapshot
Facilitating Antiviral Drug Discovery Using Genetic and Evolutionary Knowledge
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.